Paradigm Peptide
Finnrick has tested 18 samples from Paradigm Peptide across 2 products.
paradigm-peptide.com/Finnrick verified this link on 11 Nov 2025
Take Action
Request Full Data Access to the Finnrick database of peptide tests.
Products
| Tests | ||||||||
|---|---|---|---|---|---|---|---|---|
| Product | Rating | Count | Avg | Min | Max | Oldest | Most Recent | |
| Retatrutide | 7 | 24 Jul 2025 | 30 Apr 2026 | |||||
| Tirzepatide | 10 | 5 Aug 2025 | 26 Jan 2026 | |||||
The Paradigm Peptide samples tested by Finnrick were either acquired by Finnrick directly, or submitted by the public.
Most recent Paradigm Peptide tests
Samples are tested in commercial labs
tests
products
Scores
First
Last
| Quantity | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Test Date | Product | Certificate | Test Score | Label | Tested | Difference | Purity | Endotoxins | Batch ID | Container | Tested At | Sent By |
| 30 Apr 2026 | Retatrutide | View | 30mg | 31.1mg | +3.7% | 99.80% | n/a | (no batch ID) | No Label / Silver Crimp / Pink Cap | Lab G | Public | |
| 27 Apr 2026 | Retatrutide | View | Endotoxins | 30mg | n/a | n/a | n/a | low | (no batch ID) | No Label / Silver Crimp / Pink Cap | Lab G | Public |
| 26 Jan 2026 | Tirzepatide | View | 30mg | 36.2mg | +20.7% | 99.90% | n/a | jc7585 | Yellow Label / Silver Crimp / Black Cap | Lab G | Public | |
| 26 Jan 2026 | Tirzepatide | View | 60mg | 67.7mg | +12.8% | 99.90% | n/a | yh7585 | Yellow Label / Copper Crimp / Clear Cap | Lab G | Public | |
| 22 Jan 2026 | Tirzepatide | View | 60mg | 67.6mg | +12.7% | 99.90% | n/a | Yh7585 | Silver Label / Copper Crimp / Clear Cap | Lab G | Public | |
| 22 Jan 2026 | Tirzepatide | View | 5mg | 5.3mg | +6.0% | 99.60% | n/a | jc7585 | Silver Label / Silver Crimp / Blue Cap | Lab G | Public | |
| 22 Jan 2026 | Tirzepatide | View | 20mg | 21.8mg | +9.0% | 99.80% | n/a | Yh7585 | Silver Label / Silver Crimp / Violet Cap | Lab G | Public | |
About Paradigm Peptide Test Results From Finnrick
Paradigm Peptide is a peptide vendor with multiple products tracked in the independent testing dataset collected by Finnrick. This page compiles recent, batch-level test results across 2 products and 18 tests, including scores, test dates, batch IDs, and lab details. This enables you to compare quality over time, not just marketing claims.
Each tested sample receives a 0–10 score, with 10 being the best possible value. It is the total of three components: purity (0–4 points), quantity accuracy vs. the label or batch claim (0–4 points), and batch information quality (0–2 points).
When several test results are available for a product and vendor pair, you’ll also find a Finnrick Rating (A–E, where A is best and E is worst, X if an insufficient number of tests is available, or F in rare cases of documented and widespread fraud). Use the table above to review purity, quantity accuracy, consistency between batches, and any notable outliers surfaced in Finnrick testing data.
Paradigm Peptide Testing Activity & Score Summary
In the past 30 days, Finnrick has published no new test results for Paradigm Peptide, and 2 in the past three months. The overall dataset includes 18 tested samples with an average score of 8.8/10 across all products.
Across 17 identity-tested samples, 100% were confirmed to contain the expected peptide (identity pass rate). Among those that passed, median purity was 99.9%. Approximately 100% of passing samples tested at or above 98% purity.
Here is a closer look at the most frequently tested products (top 2):
- Tirzepatide (10 tests, 100% identity pass, median purity 99.9%) — Test scores are highly variable, ranging from 6.8 to 10.0 (average 8.5/10), suggesting significant batch-to-batch differences.
- Retatrutide (7 tests, 100% identity pass, median purity 100.0%) — Test scores are highly variable, ranging from 7.6 to 10.0 (average 9.3/10), suggesting significant batch-to-batch differences.